Trial Profile
Pilot study of a pegfilgrastim injection as an inducer to mobilize CD34 positive stem cells into the peripheral blood
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2020
Price :
$35
*
At a glance
- Drugs Pegfilgrastim (Primary)
- Indications Neutropenia
- Focus Therapeutic Use
- Acronyms Peg-G16 study
- 27 Apr 2018 Status changed from not yet recruiting to completed.
- 26 May 2016 New trial record